News HBM Healthcare Investments AG Swiss Exchange

Equities

Market Closed - Swiss Exchange Other stock markets 11:31:36 2024-04-22 am EDT			5-day change	1st Jan Change
186.4 ^CHF	-1.89%		-0.85%	+2.53%

Apr. 03	HBM Healthcare Investments Warns of CHF1 Million Loss for FY24	MT
Jan. 22	HBM Healthcare Investments AG Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Key Figures 15.04.2024	Apr. 16	EQ
HBM Healthcare Investments Warns of CHF1 Million Loss for FY24	Apr. 03	MT
Key Figures 31.03.2024	Apr. 02	EQ
HBM Healthcare Investments publishes net asset value per share (NAV) of CHF 248.10 as at 31 March 2024 and quarterly profit of CHF 156 million	Apr. 02	EQ
Key Figures 15.03.2024	Mar. 18	EQ
Key Figures 29.02.2024	Mar. 01	EQ
Key Figures 15.02.2024	Feb. 16	EQ
Key Figures 31.01.2024	Feb. 01	EQ
HBM Healthcare Investments AG Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 22	CI
HBM Healthcare Investments Logs Lower Fiscal Q3 Loss	Jan. 22	MT
HBM Healthcare Investments publishes Quarterly Report as at 31 December 2023 with key figures for the first nine months of the 2023/2024 financial year	Jan. 22	EQ
Key Figures 15.01.2024	Jan. 16	EQ
HBM Healthcare Investments Warns of FY24 Nine-month Net Loss	Jan. 04	MT
HBM Healthcare Investments publishes net asset value per share (NAV) of CHF 225.03 as at 31 December 2023	Jan. 03	EQ
Key Figures 31.12.2023	Jan. 03	EQ
Key Figures 15.12.2023	Dec. 18	EQ
Key Figures 30.11.2023	Dec. 01	EQ
AbbVie to Buy Cancer-focused ImmunoGen for $10.1 Billion	Nov. 30	MT
AbbVie to acquire HBM portfolio company ImmunoGen for USD 10.1 billion in cash	Nov. 30	EQ
Kepler Cheuvreux Lowers Price Target on HBM Healthcare Investments, Maintains Buy Recommendation	Nov. 21	MT

No results for this search